-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Market Perform on Dyne Therapeutics, Raises Price Target to $24

Benzinga·05/13/2026 18:38:04
Listen to the news
Bernstein analyst William Pickering maintains Dyne Therapeutics (NASDAQ:DYN) with a Market Perform and raises the price target from $23 to $24.